Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials.
Saved in:
| Title: | Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials. |
|---|---|
| Authors: | Papp KA; Probity Medical Research and Alliance Clinical Trials, 135 Union St E, Waterloo, ON, N2J 1C4, Canada. kapapp@probitymedical.com.; Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada. kapapp@probitymedical.com., Del Rosso JQ; JDR Dermatology Research, Las Vegas, NV, USA., Lebwohl MG; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Gooderham MJ; SKiN Centre for Dermatology, Peterborough, ON, Canada.; Probity Medical Research, Peterborough, ON, Canada.; Queen's University, Peterborough, ON, Canada., Hebert AA; UTHealth McGovern Medical School, Houston, TX, USA., Hong HC; Department of Dermatology and Skin Science, University of British Columbia, Surrey, BC, Canada.; Probity Medical Research, Surrey, BC, Canada., Kircik LH; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Indiana Medical Center, Indianapolis, IN, USA.; Physicians Skin Care, PLLC, Louisville, KY, USA.; Skin Sciences, PLLC, Louisville, KY, USA., Pariser DM; Eastern Virginia Medical School, Norfolk, VA, USA., Stein Gold L; Henry Ford Medical Center, Detroit, MI, USA., Strober B; Yale School of Medicine, New Haven, CT, USA., Seal MS; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA., Krupa D; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA., Chu DH; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA., Burnett P; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA., Berk DR; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA., Higham RC; Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA. |
| Source: | Dermatology and therapy [Dermatol Ther (Heidelb)] 2025 Dec; Vol. 15 (12), pp. 3733-3744. Date of Electronic Publication: 2025 Oct 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2193-8210 |
|---|---|
| DOI: | 10.1007/s13555-025-01562-4 |
